Sign In
Buy GMED
$77.95
-0.300 (-0.383%)
At Close: Jun 03, 2026
Why Is Globus Medical (GMED) Up 1.7% Since Last Earnings Report?
12:47pm, Thursday, 09'th Jun 2022
Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock?
Here's Why Investors Should Retain Globus Medical (GMED) Now
01:33pm, Tuesday, 07'th Jun 2022
Globus Medical's (GMED) strong international growth and meaningful product launches raise investors' optimism.
Globus Medical: Low Rates Sensitivity, Seeking 26% Return Objective
01:22am, Sunday, 05'th Jun 2022
Globus Medical has the credentials to outstrip peers in the shifting rates/inflation regime. The stock has traded down in recent times, widening up the value proposition.
Globus Medical (GMED) Completes First Cases With Excelsius3D
01:33pm, Thursday, 19'th May 2022
Globus Medical's (GMED) Excelsius3D, when combined with ExcelsiusGPS, facilitates greater implant placement accuracy, lowers radiation exposure and reduces operative times.
Globus Medical (GMED) Q1 Earnings Miss Estimates, Margins Dip
10:32am, Thursday, 12'th May 2022
According to Globus Medical (GMED), its Q1 results reflect modest revenue growth against a difficult prior-year comparison, coupled with COVID-related revenue impacts in key countries.
Globus Medical (GMED) Misses Q1 Earnings and Revenue Estimates
07:34pm, Tuesday, 10'th May 2022
Globus Medical (GMED) delivered earnings and revenue surprises of -8.70% and 1.22%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Globus Medical, Inc. (GMED) CEO Dan Scavilla on Q1 2022 Results - Earnings Call Transcript
05:57pm, Tuesday, 10'th May 2022
Globus Medical, Inc. (NYSE:GMED ) Q1 2022 Earnings Conference Call May 10, 2022 4:30 PM ET Company Participants Brian Kearns - Senior Vice President, Business Development & Investor Relations Dan Scav
Analysts Estimate Globus Medical (GMED) to Report a Decline in Earnings: What to Look Out for
04:33pm, Tuesday, 03'rd May 2022
Globus Medical (GMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Globus Medical (GMED) Stock Fell on Preliminary Q1 Sales Results
12:48pm, Friday, 22'nd Apr 2022
Globus Medical's (GMED) Q1 preliminary sales results reflect an increase in procedural volumes along with growth in Enabling Technologies business.
Why Globus Medical Stock Is Sinking Today
10:57am, Friday, 22'nd Apr 2022
The company's CEO unexpectedly resigned.
Globus Medical Issues Softer Outlook For Q1, CEO Resigns
08:01am, Friday, 22'nd Apr 2022
Globus Medical Inc (NYSE: GMED) announced the resignation of President and CEO Dave Demski after nearly 20 years with the company, with the last four and a half years as its CEO. The Board of Dir
Globus Medical Schedules First Quarter Earnings Release and Conference Call
04:17pm, Thursday, 21'st Apr 2022
AUDUBON, Pa., April 21, 2022 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31
Orthopedics Device Space Gaining Prominence: 3 Stocks in Focus
01:13pm, Thursday, 31'st Mar 2022 Zacks Investment Research
Stocks like Orthofix Medical Inc. (OFIX), Stryker Corporation (SYK) and NuVasive, Inc. (NUVA) are likely to gain enormously from developments in the orthopedic space.
Orthopedics Device Space Gaining Prominence: 3 Stocks in Focus
10:32am, Thursday, 31'st Mar 2022
Stocks like Orthofix Medical Inc. (OFIX), Stryker Corporation (SYK) and NuVasive, Inc. (NUVA) are likely to gain enormously from developments in the orthopedic space.
Where Globus Medical Stands With Analysts
08:24pm, Monday, 28'th Mar 2022 Benzinga
Analysts have provided the following ratings for Globus Medical (NYSE:GMED) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
3
2
0
0
La
